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 Currently, TLDs and Gafchromic EBT3 film are commonly used for skin dose 
measurement during Total Skin Electron Therapy (TSET). However, measurements using 
these dosimeters is very time consuming due to post-irradiation processing requirements. 
Also, accurate skin dose measurements are challenging with these dosimeters since the 
radiosensitive layer of the skin sits at an approximate depth of 0.07mm. The MOSkin 
detector has advantages of being of a small physical size and submicron dosimetric 
volume and a water equivalent depth of 0.07mm while providing real-time dosimetry. 
Measurements of the MOSkin’s dosimetric characteristics were performed using 
a 6 MeV electron beam with an Elekta Infinity linear accelerator at the Prince of Wales 
Hospital. For the TSET measurements, doses measured with the MOSkin detector were 
directly compared to TLDs and Gafchromic EBT3 film using a 6 MeV high dose rate 
electron (HDRE) beam. A 6 mm Perspex spoiler was placed and aligned perpendicularly 
to the beam in order to lower the effective beam energy and improve dose homogeneity. 
MOSkin dose response was observed to be effectively linear over 3 Gy of the total 
dose. The response of the MOSkin showed the expected increase in surface dose with 
incident beam angle. For dose rate response, the effect on the MOSkin’s measurements 
was not significant. For the TSET measurements, all three detector types showed a very 
similar trend of dose readings over every measurement points. 
The MOSkin is an effective skin dosimeter for TSET dosimetry as it provides 
stable skin dose readings that compared acceptably with the TLD and EBT3 film results. 
It also showed good dose linearity and dose rate independence for 6 MeV electron beam 
and behaved very similarly to the other types of dosimeters that are commonly used for 
TSET in vivo dosimetry.
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Skin dose measurement can be important during radiation therapy to verify the 
delivery of a prescribed dose to the targeted cutaneous area. A dosimetric technique used 
to assess the dose to the skin surface and underlying tissue is called in vivo skin dosimetry. 
In vivo dosimetry can be used at points all over a patient’s body particularly for patients 
receiving total body irradiation (TBI) or total skin electron therapy (TSET). 
Traditionally, thermoluminescent dosimeters (TLDs) and film have been used 
most commonly for in vivo dosimetry on TSET because, compared to other types of 
dosimeters, they are cheap, can be prepared into various sizes and point doses can be 
measured across multiple areas of a patient’s body at the same time. Also, no external 
voltage supply is required and therefore no cables are attached when operating them.  
However, measurement using these dosimeters is very time consuming due to pre- and 
post-irradiation processing requirements. Also, accurate skin dose measurements are 
challenging with these dosimeters since the radiosensitive layer of the skin, called basal 
cell layer, sits at an approximate depth of 0.07mm (5). An ideal in vivo skin dosimeter 
should be tissue equivalent, small in physical size with a thin water equivalent depth 
(WED) to measure the dose at the basal cell layer level, consistent with factors such as 
temperature and energy (6). Also, it should not disturb the radiation field, be safe to use 
directly on a patient’s skin, angular independent, and provide a real-time dose reading for 
fast and accurate skin dose reading (6). 
The MOSkin detector could be a good alternative to traditional in vivo skin 
dosimeters for TSET. It has advantages of being of a small physical size and submicron 
dosimetric volume and a water equivalent depth of 0.07mm while providing real-time 
dosimetry. MOSkin detectors have previously been investigated as dosimeters in external 
beam radiation therapy and brachytherapy and subsequently has been characterised for 
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megavoltage and kilovoltage photon beams. However, application and characterisation 
of the MOSkin detector for megavoltage electron beam therapy have not been studied and 
therefore the aims of this project are 
• Characterisation of MOSkin detector in 6 MeV electron beam (the only beam 
energy setting used for TSET at the Prince of Wales Hospital) 
• Comparing the dose readings with TLD and Gafchromic EBT3 film under TSET 




2. LITERATURE REVIEW 
2.1 Electron beam therapy 
 Electron beam therapy is a type of external beam radiation therapy used for the 
treatment of tumours at shallow depth. The electron beam has a property of limited 
penetration range and rapid dose fall off and so it is useful for skin cancer, electron boost 
for breast cancer and nodes (7). Electron beams can provide a uniform distribution of the 
dose to the target volumes at a specific depth while providing the optimum tissue sparing 
effect for the deeper tissue (7, 8). 
In the late 1930s, Van de Graaff and Trump developed the first electron beam 
radiotherapy machine called the Van de Graaff accelerator (9, 10). It generated electron 
beams with an energy less than 3 MeV and therefore was only used for treating surface 
lesions (9). Then, in the late 1940s, a machine called a Betatron was developed and used 
for accelerating electrons with an energy up to tens of MeV (11). High energy electron 
beam radiation therapy has been performed since the early 1950s (8, 12). Initially, the 
therapeutic application of a 6 MeV betatron was first performed by Gund and Paul in 
Germany in 1950 (13). Then the modern high energy linear accelerator (linac), with the 
capability of producing both photon and electron beams became more commonly used (8, 
12). In the early 1980s, the electron pencil beam algorithms were developed and 
implemented for dose calculation.  
An electron is a charged particle with very small mass of approximately 9.11 x 
10-31 kg. When it enters a medium, it undergoes multiple interactions with atoms within 
the medium which results in direct energy loss or scattering or a combination of both in 
random directions (1). This random process limits the energy distribution range and 
therefore results in a sharp dose fall at shallow depth as appeared on figure 1. The depth 
where the absorbed dose reaches the maximum (dmax) increases with energy. At lower 
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energies up to 20 MeV, an electron beam delivers 90 to 100 % of maximum dose up to 6 
cm depth and the dose falls off rapidly with depth so that it allows to spare the underlying 
tissues (9). However, as the beam energy increases, depth dose curves of electron beams 
lose their property of rapid dose fall off and the photon contamination appears due to 
increased Bremsstrahlung production (9). Thus, electron beams with the energies in the 
range of 6 to 20 MeV are normally used for treating shallow tumours (9). Clinically, 
electron beam therapy is typically performed for treating skin and lip cancers, post-
surgery or recurrent cancer on chest wall and neck, upper respiratory and digestive tract 
lesions within 6 cm in depth, and boost treatment to the tumour bed after mastectomy or 
lumpectomy (9). 
 
Figure 1. Central axis percentage depth dose (PDD) curves of electron beams with various energies at 100 
cm SSD using a 10 cm x 10 cm applicator. Beam data obtained from Elekta Infinity linear accelerator at 

































2.2 Electron beam production and delivery 
In linear accelerator, the electron beam is originated from the electron gun. An 
electron gun consists of a cathode and an anode. The cathode is a tungsten filament which 
releases electrons when heated. Electrons are then attracted towards the perforated anode 
and being focused as they are passing through the hole in the anode (4). They are then 
injected into the bunching section of the accelerating waveguide and electrons bunches 
are then accelerated close to the speed of light by radio frequency (RF) pulsed 
microwaves while travelling along the waveguide tube (1). The RF microwaves are 
generated by either a magnetron or a klystron and have a frequency of about 3GHz (1, 4). 
The choice of the type of RF microwave generator is depending on the design 
requirements and manufacturer’s preference. After being accelerated, the pulsed electron 
beam is bent toward the patient and refocused by the bending magnets. In general, either 
a 270 degree or a 112.5 degree (also known as slalom system) bending magnet system is 
used for linear accelerator depending on the design requirements and manufacturer’s 
preference. After passing the exit window, the electron beam has a diameter of a few 
millimetres, and therefore a scattering foil is necessary to spread out the beam for clinical 
use (1, 4). Electron applicators with levels of collimation planes are used to achieve a 
relatively well defined edge of the electron beam (4). 
 
2.3 Electron interactions with matter 
When electrons in the energy range used in electron therapy enter material, they 
transfer their energy continuously via many interactions with atoms along their trajectory. 
So, the energy of electron beam decreases with the depth in tissue  (4). The most important 
electron interactions include collisions with orbital electrons and coulombic interaction 
with the nuclei of atoms (1, 4). 
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Collisions are of major interest since these events result in direct energy 
deposition within the medium and the probability of collisional energy loss depends on 
the energy of the incident electron and the atomic number of the medium (1, 4). 
Collisional energy loss occurs when a fast moving electron approaches close enough to 
remove an atomic electron from its orbiting shell temporarily or permanently (4). If the 
incident electron is temporarily removed from its orbiting shell, the electron is 
temporarily elevated to a higher energy level and so the atomic electron becomes excited. 
Then the emission of a visible light photon occurs when the temporarily excited electron 
goes back to the lower energy level. 
 
Figure 2. Electron interaction process: Excitation. (Adapted from (1)) 
 
If the incident electron has greater energy than the binding energy of an orbiting 
electron and permanently removes an orbiting electron of an atom, the atom becomes 




Figure 3. Electron interaction process: Ionisation. (Adapted from (1)) 
 
Radiative energy loss occurs when the incident electron interacts with the nucleus 
of an atom and the probability of such energy loss depends on how closely the incident 
electron approaches the nucleus. The probability increases if the distance between the 
approaching electron and the nucleus of the atom decreases (1, 4). When the incident 
electron approaches closely to the nucleus of an atom, it will experience nuclear Coulomb 
force and be deflected from its trajectory and loses its energy as a form of electromagnetic 
radiation so-called Bremsstrahlung radiation as appeared on figure 4 (1, 4). This process 
is called radiative energy loss as the kinetic energy of the incident electron is converted 




Figure 4. Electron interaction process: Bremsstrahlung production. (Adapted from (1)) 
 
The emission of characteristic K radiation also occurs if ionisation occurs in the 
K-shell of the atom (1). After the removal of the K-shell electron, a vacancy is created 
and an electron from L or M shell fills this vacancy and the energy difference between 
the binding energies of inner and outer shells is emitted as a form of electromagnetic 
radiation so called the characteristic K-radiation (1). 
 




2.4 Total skin electron therapy 
Total Skin Electron Therapy (TSET) is a type of electron beam therapy that was 
first introduced in the 1950s to treat mycosis fungoides (MF) (14). MF is a type of 
cutaneous T-cell lymphoma (CTCL) which is a lymphoproliferative disorder 
characterised by localisation of malignant T lymphocytes to the skin and to the T-cell 
zones of lymphoid structures (15, 16). MF is the most common type of CTCL and it 
accounts 80 to 85% cases of CTCL (15). It was first described by Alibert in 1806 and the 
term ‘mycosis fungoides’ was used due to its mushroom-like tumour shape. MF is 
classified into three different stages; patch stage, plaque stage, and tumour stage 
depending on the clinical appearance (17). It is hard to cure and treatment is usually 
palliative to relieve symptoms and improve the quality of life. However, patients 
diagnosed in early stage have significant longer term survival (18). 
 
Figure 6. Different stages of mycosis fungoides (MF). Pictures reproduced with permission from DermNet 
New Zealand (2) 
 
Several treatment options are available depending on the stage of the disease. For 
patients with patch or plaque stage MF generally receive skin-directed therapies using 
corticosteroids or topical chemotherapy (19). Systemic therapies are the option for 
advanced stage disease or for patients who do not respond to skin directed therapies (19). 
Radiotherapy is an effective treatment option for treating MF because the malignant T 
10 
 
lymphocytes are the most radiosensitive of all cells (20). Radiotherapy can be delivered 
either locally (in unilesional or oligolesional disease) or entirely on patient’s skin area 
with palliative or curative purpose (19). 
TSET aims to deliver a uniform prescribed dose to the entire patient’s skin surface 
to a specified depth (21). Several irradiation techniques are used and the three most 
commonly are: six static dual-field technique, eight static dual-field technique, and 
rotational technique. The six static dual-field technique also known as the Stanford 
technique was introduced by Page et al. at Stanford University in 1970 (3, 22). It is the 
most widely used technique and, as the name suggests, this treatment technique involves 
six angular orientations (60 degree intervals as shown on figure 7). The patient stances 
for each angle are appeared on figure 8. The TSET dose is delivered in two fields (superior 
and inferior) at each angle while the patient is standing to provide sufficient dose 
uniformity over the patient’s height and width (3). 
 





Figure 8. Six patient stances: (Clockwise from top left) left anterior oblique, anterior, right anterior oblique, 
right posterior oblique, posterior, left posterior oblique. Pictures reproduced with permission from AAPM 
Report No. 23 (3) 
 
However, studies have found that the six dual-field technique provides 
considerably less dose uniformity than the eight dual-field and the rotational techniques 
due to the body curvatures, varied angles of incident electrons, and a finite number of 
patient orientations (3). The human body is not cylindrical and therefore there are some 
shaded areas where the dose received is lower than other parts of the body (3). According 
to AAPM Report 23, the rotational technique provides the best dose uniformity and the 
eight dual-field technique provides almost the same (3). During rotational irradiation, the 
patient stands on a rotating platform and the TSET dose is delivered in two fields with 
gantry angles of 90 ± 18º while the patient is rotating (23). It is also advantageous for 
reducing the treatment time so that the patient does not need to hold the required positions 




Figure 9. The angular orientation of the eight static dual-field technique 
 
Modern linear accelerators offer high dose rate (HDR) electron beam option to 
deliver 1000 or more monitor units (MU) per minute. This option is useful for reducing 
the treatment time as TSET treatment involves multiple orientations and the patient needs 
to hold the required stances while irradiating each orientation. TSET is performed using 
electron beams with nominal energies of 4 to 10 MeV at the linear accelerator, also called 
a linac, exit window(3).  The mean beam energy then decreases as the beam passes from 
the exit window to the treatment plane (3).  A thin scatterer, also known as a spoiler, is 
placed in front of the treatment plane when performing TSET treatments to reduce the 
electron beam energy to a desired level (3 to 7 MeV at the patient’s skin) and to improve 
electron uniformity (3, 4). The spoiler causes the incident electrons to scatter before 
reaching the treatment plane to further spread out the electrons and improve dose 
uniformity. 
The most probable energy at the phantom surface can be obtained from the range-
energy relationship: 
𝐸𝑝,0 = 1.95 𝑅𝑝 + 0.48 MeV          (1) 
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where Rp is the practical range in cm in water (25). The mean electron energy at the 
surface of the phantom can be calculated by, 
𝐸0 = 2.33 𝑅50 MeV          (2) 
where, R50 is the depth of half maximum dose in cm in water (3, 25). 
At Prince of Wales Hospital, TSET is performed using a 6 MeV high dose rate 
electron (HDRE) beam. A rotational irradiation technique is used and the dose is 
delivered in two beams at gantry angles of 252º and 288º for upper and lower body while 
the patient is rotating at a speed of 25.8 seconds per rotation. A 6 mm Perspex spoiler is 
used and aligned perpendicularly to the beam in order to lower the effective beam energy 
and improve dose homogeneity. The R50 and Rp calculated from the PDD curve of 6 MeV 
HDRE beam under TSET treatment conditions with a 6 mm spoiler, appeared on figure 
22, are 12.3 mm and 20.8 mm respectively. So, the E0 and Ep,0 at the surface of the 
phantom are approximately 2.9 MeV and 4.5 MeV respectively. 
 
2.5 Radiation detectors used for surface dosimetry 
2.5.1 Thermoluminescent dosimeters 
 Thermoluminescent dosimetry (TLD) is one of the most widely used technique 
for in vivo dosimetry for many types of external beam radiotherapy and brachytherapy, 
and it was first used for ionising radiation almost 100 years ago (26-28). A variety of TL 
detectors are available for TLDs including capsule type (TL powder encapsulated in a 
capsule), carbon loaded LiF disks, LiF:Mg,Cu,P chips and so on (4). Among those, the 
most commonly used TL detector for in vivo dosimetry is TLD-100 (LiF:Mg,Ti) (4, 29). 
TL detectors have advantages of being in small size, reusable, and no cables required (4, 
29). They are used for point dose measurements and can be directly attached to the 
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patient’s skin for in vivo dosimetry. It is regarded as a gold standard for in vivo dosimetry 
and provides the best results with the tolerance range of ± 10 % for TSET (30-35). 
 TLDs are non-conducting in general and all electrons are within the valence band 
in energy band model at room temperature (4). A number of imperfections such as 
Magnesium (Mg), Titanium (Ti), Copper (Cu), Phosphorus (P) are added to the crystal 
and sit within the energy gap between the conduction and valence bands. When the crystal 
is irradiated by ionising radiation, some electrons gain enough energy to move up to the 
conduction band (excitation). After the irradiation, these electrons return back to 
equilibrium state (relaxation) to the valence band, however, approximately 1% of the 
electrons are trapped by the imperfections (metastable state) (4, 36). The number of 
electrons trapped by the imperfections is proportional to the intensity of the incident 
radiation (4). Excitation of these trapped electrons occurs with external heat so that the 
escaped electrons move up to the conduction band. These electrons then lose their energy 
as a form of visible light and fall back to the valence band. The light signal is then 
registered by a photomultiplier tube (PMT) and the amount of emitted light is proportional 
to the absorbed dose (4, 29). Thermal annealing process must be performed to remove 
residual signals every time before use (29). 
 There are factors affecting the TLD dose readings. Supra-linearity of TLDs occurs 
when measuring doses higher than 1 Gy. The concentration of titanium (Ti) affects the 
supralinear response of TLDs. Higher Ti concentration shifts the onset of supralinear 
response to higher doses (4). Supra-linearity can also be affected by the glow curve peak. 
Higher glow peak number can cause the onset of supralinear response at lower doses (4). 
Annealing temperatures and the cool down rate can also affect supra-linearity of TL 
material (4, 36). The energy dependence of the TLDs should be considered as the dose 
response varies with the beam quality and also influences supra-linearity response (4, 29). 
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If TLDs are calibrated in a Co-60 photon beam, corrections for energy dependence can 
be made by multiplying factors of 1.01 and 1.025 by the doses measured with 6 MV and 
25 MV photon beams respectively and factors of 1.04 and 1.03 by the doses measured 
with 2 MeV and 20 MeV electron beams respectively (37-39). However, according to the 
International Atomic Energy Agency (IAEA) Human Health Reports No. 8, it is simpler 
to calibrate TLDs against an ionisation chamber in the same beam energy as used for the 
measurements (37). Fading can result in a reduction of TL signal. After irradiation, the 
electrons trapped in imperfections gain energy at room temperature and escape out with 
the emission of light. So, the TL signal decreases with time. The probability of fading is 
inversely proportional to the difference between the conduction and valence bands, also 
known as the energy gap (4, 29). That is, narrower the energy gap higher the probability 
of fading. This effect could be minimised if all TLD readings are performed with the same 
time delay after the irradiation (29). TLDs are also time consuming as it requires 
calibrations for each TL dosimeter to provide accurate dose reading. 
 
2.5.2 Radiochromic film 
 Radiochromic film has many advantages over radiographic film. It is almost 
completely energy independent for x-ray beams over a therapeutic range from 6 MV to 
15 MV, and electron beams over a therapeutic range from 6 to 22 MeV (40, 41). It is 
flexible, almost completely tissue equivalent and provides high two-dimensional (2D) 
spatial resolution and can be prepared in various shapes and sizes which make the film a 
favourable tool for measuring skin dose. Also, unlike radiographic film, no chemical 
processing is required after irradiation due to its self-developing capability and therefore 
eliminates processing discrepancies (4). The active layer of radiochromic film contains 
diacetylenes which turns blue or red through a polymerisation process upon irradiation 
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(29, 42, 43). In particular, Gafchromic EBT films use the lithium salt of pentacosa-10,12-
diynoic acid (LiPCDA) which allows the films can be used at doses as low as 1 cGy (44, 
45). Gafchromic EBT3 film consists of a 28 µm thick active layer sandwiched between 
two, 125 µm thick, polyester layers (42). Optical densitometry is used to assess changes 
in colour quantitatively by using a densitometer (4). Within the densitometer, the optical 
density (OD) can be calculated from the ratio between the intensity of light emitted from 
the light source from one side of the film, Φ0, and the transmitted light detected from the 
other side of the film, Φ (4). Optical density is calculated by: 
OD = 𝑙𝑜𝑔10 (
Φ0
Φ
)          (3) 
According to the EBT3 vendor specification and user guide provided by Ashland 
Inc., a 48-bit (16-bit per channel) flatbed colour scanner is recommended for EBT3 film 
dosimetry (42). EBT film exhibits orientation dependence and variations in net OD were 
found approximately 15%, and 4% at the dose levels of 50 cGy and 3 Gy respectively 
(46). This occurs because the film consists of various layers and therefore its construction 
causes the light scattering effect (polarisation) with varying rotational reference when 
scanning (46). So, it is essential to scan EBT3 film with the same orientation every time 
when performing film dosimetry (29). The scanner’s flatbed surface needs to be cleaned 
every time prior to placing the film to remove any specks of dust and the film surface 
should be in contact uniformly on the flatbed to prevent the production of scanning 
artefacts such as Newton’s ring (47). A scanner warm-up procedure needs to be carried 
out by running the scanner several times before scanning the film to stabilise the scanner 
signal. 
According to Bufacchi et al., radiochromic film provides reliable dose verification 
for in vivo dosimetry for TSET (34). The study was performed by using a six dual-field 
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technique and a 6 MeV electron beam and doses measured with the EBT film were 
directly compared to TLDs. They concluded that the EBT film provides a good agreement 
with TLD and the percentage differences between EBT film and TLD readings measured 
on 20 different spots on 80 patients’ body were mostly within ± 5% (34). 
 
2.5.3 Parallel plate ionisation chamber 
 The ionisation chamber is the most commonly used dosimeter in radiotherapy and 
the principle of operation is well understood for clinical use. It is reliable and easy to 
operate and provides accurate dose readings in real-time and therefore recognised as the 
standard for calibration and used to compare with other dosimeter types (4). It has 
characteristics of excellent dose linearity, directional independence (particularly to the 
thimble type ionisation chamber) and almost energy independent over a wide radiation 
energy range (48, 49). Most ionisation chambers use air as an active medium and 
correction factors that are required to determine absorbed dose to water are well 
established in ionization chamber dosimetry (4, 50). These includes perturbation factor, 
chamber-dependent conversion factors for converting the air kerma (kinetic energy 
released per unit mass) to absorbed dose, and atmospheric factors such as temperature, 
pressure and humidity (10, 50). Calibration of ionisation chambers is performed by using 
a cobalt-60 γ-ray beam either for air kerma in air, exposure, or for absorbed dose to water 
at a primary standards laboratory (51). Therefore, the calibration coefficients for absolute 
dosimetry are known and available to be used for clinical radiation sources (51). When 
the incident photons enter the ionisation chamber, some photons interact with the air 
molecules and produce secondary electrons while some photons are scattered and escape. 
Secondary electrons then interact with the atoms of the air and results in ionisation and 
deposition of kinetic energy. Some electrons lose energy via radiative energy loss such 
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as Bremsstrahlung and characteristic x-rays. Ions produced from the ionisation are then 
collected using an electric field and the charge is measured for dose reading (4). The 
applied voltage (U) used for ionisation chamber is approximately 100 V to 400 V (4). 
 A few factors should be corrected for absolute dosimetry when using ionisation 
chamber. Temperature and pressure can vary the number of air molecules in vented 







)          (4) 
Where pr is the reference pressure (101.3 kPa), p is the measured pressure, Tr is the 
reference temperature (295.2 K or 22 °C), and T is the measured temperature (4, 52, 53). 
The influence of humidity is usually negligible because all therapeutic dosimeters are 
built to keep humidity well below 1 % (54). However, at higher humidity, moisture on 
the surfaces can cause leakage from the chamber and electrometer. So, leakage must be 
monitored when taking measurements with chambers that are built with a hygroscopic 
material such as A-150 plastic or nylon (4). The effect of polarity should also be checked 
because the ion charge readings could be different depending on the direction of the 
voltage polarity of ionisation chamber (4). The effect is significant when the dose reading 
is performed in charged particles such as electrons while the effect is very small in photon 
beams (10, 50). Correction can be made by taking measurements at both polarities and 
the true reading is the mean value of the absolute values of two readings (4, 10, 50). The 
recombination of electrons and ions result in a loss of charge collection within the 
ionisation chamber and therefore a loss of signal. This effect is significant in pulsed 
radiation beams from a linac that are used in radiotherapy and can cause an effect of more 
than 1% in readings, while it is almost negligible for continuous radiation beams. This 
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ionic recombination effect also needs to be corrected when using an ionisation chamber 
(10, 50). 
 Parallel plate ionisation chambers are good for surface dose measurements 
because unlike thimble type chambers, they have a wide, flat entrance window and narrow 
plate separation. For example, a commercially available Attix chamber has a wall 
diameter of 40 mm, window thickness of 0.025 mm (4.8 mg/cm2), and plate separation 
of 1 mm (4, 55). The Attix chamber is reliable for surface dose measurements and, with 
the Rawlinson correction, gives a high accuracy of ± 0.5 % for 6 and 24 MV photon 
beams (13, 18). Compared to other plane parallel plate ionisation chambers, it has a wide 
guard ring which provides improved field homogeneity and minimises the perturbation 
effect. So, it prevents the secondary electrons that are scattered from inside of the detector 
side wall being counted by the collecting electrodes (4). Extrapolation chambers can also 
provide accurate dose measurements at very shallow depth. However, dosimetry with the 
extrapolation chamber is time consuming (56). Also, using parallel plate ionisation 
chambers are clinically impractical for in vivo dosimetry due to their large size and rigid 
structure (57). Furthermore, since an ionisation chamber uses high bias voltage of 
approximately 100 V to 400 V, they cannot be used on patients due to safety issues. 
 
2.5.4 Metal oxide semiconductor field effect transistor dosimeter 
Metal oxide semiconductor field effect transistor (MOSFET) is a type of transistor 
that amplifies or switches the electronic signals. With its small dosimetric volume, it has 
advantages of immediate dose readout and permanent data storage. In 1974, Andrew 
Holmes-Siedle suggested the use of MOSFET in space-charge dosimetry and, since then 
it has been used as a monitor for radiation damage of spacecraft (58, 59). Space-charge 
refers to the charge density that is trapped in the dielectric (insulating material) due to the 
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effect of ionising radiation. The increase of radiation induced charge density results in a 
change of the dielectric surface potential which is proportional to the radiation dose (59, 
60). 
A MOSFET consists of a silicon substrate, three terminals; gate, source and drain 
and an insulating silicon dioxide (SiO2) layer as illustrated in Figure 10. The SiO2 layer 
acts as an insulator and sits in between the gate and the silicon substrate. The source and 
drain sit on the silicon regions that are doped with opposite charge to the silicon substrate. 
The MOSFET can be either a ‘p’ or ‘n’ channel device depending on the type of silicon 
substrate. For example, an n-channel MOSFET (nMOSFET) device is made of a 
positively doped silicon substrate and electrons are the charge carriers for conducting the 
channel current from the source to the drain. Whereas a p-channel MOSFET (pMOSFET) 
device has the n-type silicon substrate and holes are the charge carriers. The channel 
region forms just under the SiO2 layer and connects the source and the drain. 
 
Figure 10. Structure of the nMOSFET detector 
 
A bias voltage is applied to the gate (Vg) and the conductivity of the MOSFET is 
controlled by varying the gradient of Vg. Depending on the type of silicon substrate, Vg 
can be either positive or negative. The MOSFET is in its off state when the Vg is at zero. 
The gate voltage that is required for current to flow through the conduction channel 
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between the source and the drain is known as the threshold voltage (Vth) and the MOSFET 
dosimetry involves the measurement of the change in Vth (ΔVth). When irradiated, 
ionising radiation causes the production of electron-hole pairs within the SiO2 layer. The 
minimum energy required to produce an electron-hole pair in SiO2 is approximately 18 
eV (61). For a nMOSFET detector, positive Vg induces an electric field that causes the 
electrons to move towards the gate and the holes move towards the Si-SiO2 interface. The 
electrons move faster, approximately four times faster than holes at room temperature, 
and escape through the gate contact. Whereas holes move through the oxide and are 
trapped near the Si-SiO2 interface. The trapped holes remain near the interface and build-
up a positive charge layer. The conduction channel region between the source and the 
drain sits directly below the Si-SiO2 interface within the silicon substrate. The trapped 
charges interfere with the current flow in the channel and therefore a larger gate voltage 
is needed for constant current flow between the source and drain (61). The threshold 
voltage, Vth, refers to a certain amount of Vg that is required to maintain a constant current 
flow through the channel and a change in Vth is proportional to the absorbed dose received 
(4). Therefore, the difference in gate voltage is calculated by 
∆𝑉𝑡ℎ = Vg,post − Vg,pre          (5) 
where Vg,post is the gate voltage after the irradiation and Vg,pre is the one before the 
irradiation. MOSFET detectors can be operated in either active mode, with the gate 
voltage supply, or passive mode, without the gate voltage supply (61). The ΔVth response 
of a pMOSFET in active and passive mode can be predicted by simple electrostatic 
analysis with equations below. 
In active mode: ∆Vth = 0.04 D tox
2  f          (6) 
In passive mode: ∆Vth~ 0.0022 D
0.4 tox
2           (7) 
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where D is the dose in cGy in the oxide, tox is the thickness of oxide in µm, and f is the 
fraction of generated holes that do not recombine (61-63). With the increase in positive 
bias, the parameter f becomes 1 (61). However, in general, the response of pMOSFETs 
are sub-linear in passive mode due to the repulsive coulomb interaction produced by the 
trapped holes near the interface and the response is modelled as 
∆Vth = V0 [1 − exp(−βD)]          (8) 
On the other hand, the dose response in active mode is effectively linear over a wide dose 
range (21). The thickness of oxide layer and the electrical field in the oxide largely affect 
the response of MOSFET device (21). 
 A MOSFET detector is small in size so it provides a good spatial resolution and 
shows very little beam attenuation that is advantageous to be used for in vivo dosimetry 
(29). It also provides near real-time dose readout unlike other in vivo dosimeters such as 
TLDs and films. Many studies have been performed using MOSFET detectors for in vivo 
dosimetry. These include dosimetry in a total body irradiation (TBI) (64), intensity 
modulated radiation therapy (IMRT) (65), serial tomotherapy (66), image guided 
radiation therapy (IGRT) (67), brachytherapy (14, 61), and microbeam radiation therapy 
(68). 
There are factors that need to be considered when using MOSFETs for radiation 
dosimetry. MOSFETs show a decrease in sensitivity with respect to the total absorbed 
dose and exhibit energy dependence as they are made of silicon (4, 29). So, corrections 
are necessary when using single MOSFETs (4). Their reading drifts slightly after the 
exposure and therefore a consistent delay must be made when readings are taken after 
each exposure (4, 37). 
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MOSFETs are also temperature dependent. According to Cheung et al., the Vth of 
MOSFET varies with the temperature and the level of variations is dependent on the dose 
history (67). However, they also reported that this temperature dependence is almost 
insignificant within the temperature range of 15 ºC to 40 ºC with variations less than 1.5 % 
(67). For accurate dose measurements, the temperature effect could be resolved by using 
dual MOSFET system which involves using two MOSFET detectors on the same 
substrate but with different gate bias voltages (61). This system provides error reduction 
by subtracting signals from each MOSFET after irradiation. Errors could also be 
minimised if the voltage reading before and after irradiations were performed at the same 
temperature even though the temperature during irradiation varies (67). So, when used 
for in vivo dosimetry, the detector needs to be attached to the patient’s body and kept for 
at least a minute to allow thermal equilibrium to occur before the initial reading. Then, 
after the irradiation, post irradiation reading needs to be performed before removing the 
detector from the patient (67). Alternatively, take post irradiation reading at least 2 
minutes after removal from the patient to allow the detector to cool down to room 
temperature if pre-irradiation reading was performed at room temperature (67). 
Commercially available MOSFET detectors use an epoxy bubble as a build-up 
layer and the sensitive volume of the MOSFET chip is enclosed within it. This epoxy 
bubble provides approximate water equivalent depth (WED) of 0.6 to 1.8 mm which is 
inappropriate for accurate skin dose measurements since the radiosensitive layer of the 
skin, called basal cell layer, sits at an approximate depth of 0.07 mm (5). 
 
2.5.5 MOSkin detector 
The MOSkin detector, designed by the Centre for Medical Radiation Physics 
(CMRP) at the University of Wollongong, could be an effective skin dosimeter for 
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electron beam therapy. It is a MOSFET based detector and it consists of a 350 µm thick 
p-type MOSFET which has a 0.55 µm thick gate oxide (57, 69). As seen in the figure 11, 
the major differences between the MOSFET and MOSkin are the packaging and their 
build-up layers. Within a typical MOSFET detector, the MOSFET chip sits on the surface 
of the chip carrier packaging and is covered by an epoxy bubble as a build-up layer that 
produces WED of approximately 0.6 to 1.8 mm. However, in MOSkin detector, the chip 
is dropped below the packaging surface and is hermetically sealed by a highly 
reproducible tissue equivalent build-up layer (57, 69). The build-up layer can be varied 
when manufactured in order to produce a desired WED (69). 
 
Figure 11. Comparison of packaging between (a) commercially available MOSFET detector and (b) the 
MOSkin detector (reproduced from (57, 69)) 
 
Several studies have proved that the MOSkin detector is an effective dosimetric 
tool for skin dose measurements. Kwan et al. performed skin dose measurements with six 
individual MOSkin detectors with a 6 MV photon beam and its response about the 
detector azimuth with an Ir-192 source used for HDR brachytherapy. They concluded that 
the MOSkin detector provides excellent surface dose readings in a 6 MV photon beam 
with angular dependence of less than 2 % and their angular response about the detector 
azimuth for Ir-192 source is within 2% over all angles (69). Qi et al. reported that the 
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MOSkin detector showed good agreement with the Attix chamber and EBT Gafchromic 
film for the dose measurements in a 6 MV photon beam at the surface and build-up region 
both perpendicularly and up to 75 degrees of obliquely incident beams (57). In 2014, Jong 
et al. performed characterisation of the MOSkin detector on the phantom surface in 6 and 
10 MV photon beams and proved that the MOSkin detector is suitable for surface dose 
measurements (6). They stated that the MOSkin detector shows excellent dose linearity 
and reproducibility, source to surface distance dependence of less than 2% over a range 
of 80 to 110 cm and good agreement with the Attix chamber for angular dependence when 
it is in face-up orientation (6). The maximum difference was found to be 18.5 % when 
the MOSkin is in face-down orientation. Therefore, the MOSkin detector should be 
positioned in face-up orientation when it is used for skin dosimetry (6). The angular 
dependence of MOSkin detector may be different for electron beams due to the different 





3. MATERIALS AND METHODS 
3.1 Linear accelerator 
 All measurements were performed with an Elekta Infinity linear accelerator 
(Elekta AB, Stockholm, Sweden), shown in Figure 12, at the Department of Radiation 
Oncology at the Prince of Wales Hospital. 
 
Figure 12. Elekta Infinity linear accelerator at the Department of Radiation Oncology at the Prince of Wales 
Hospital 
 
Measurements for calibration, dose linearity, percentage depth dose and angular 
response were performed with a 10 cm x 10 cm electron applicator. A 40 cm x 40 cm 
‘applicator’ was used for the TSET measurements although this was merely a type of 
physical interlock to allow the machine to set a 40 cm x 40 cm field size defined by the 
secondary collimator jaws which is not allowed for normal electron beams for treatment 
at isocentre. The nominal output of the 6 MeV electron beam of this linear accelerator 
was calibrated with a traceable (to a secondary standards laboratory) ionisation chamber 
to deliver 1 cGy per monitor unit (MU) at dmax of 13 mm in water. A MU is a defined as 
a unit of measure of the dose output by the accelerator measured by a pair of ionisation 
chambers located below the radiation source (the target or the electron scattering foils) 
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within the linac treatment head (4). For any exposure, the linear accelerator is 
programmed to deliver a certain amount of monitor units which the ionisation chambers 
detect and shut off the beam when the programmed monitor units are delivered.  
 
3.2 Phantoms 
Various thicknesses of 30 cm x 30 cm sized Solid Water phantoms (Gammex RMI, 
Middleton, WI, USA) and a Plastic Water phantom (Computerized Imaging Reference 
Systems Inc., Norfolk, VA, USA) that has a shallow groove, approximate depth of 0.5 
mm, for the MOSkin were used for characterisation of the MOSkin detectors at different 
depths. For TSET measurements, a cylindrical Perspex phantom (length = 18.5 cm, 
diameter = 18 cm) (Lucite International, Southampton, UK) was used with three different 
types of detectors (Gafchromic EBT3 film, TLD, and MOSkin). A 6 mm Perspex spoiler 
sheet with a dedicated wooden frame were used and placed in front of the rotating 
platform (a distance of 85 cm from the axis of rotation as was used clinically). 
 
Figure 13. A cylindrical phantom (left) and the setup (right) used for TSET measurements 
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3.3 MOSkin detector 
 The Centre for Medical Radiation Physics (CMRP) designed MOSkin detector 
and its electrometer for the gate threshold voltage reading are shown in Figure 14 and 15. 
 
Figure 14. MOSkin dosimeter developed by the Centre for Medical Radiation Physics (CMRP) at the 
University of Wollongong. (a) Connector pin end, (b) MOSkin sensor end (face down), (c) MOSkin sensor 
end (face up) 
 
The MOSkin detector with the connecting cable strip used in these experiments 
was 33 cm long, 3 mm wide, and approximately 0.5 mm thick externally. The MOSkin 
detector was connected to the CMRP designed Clinical Semiconductor Dosimetry System 
(CSDS) via a cable for dose reading. CSDS is a battery powered electrometer that can 
read the gate threshold voltages of up to five MOSkin detectors simultaneously. The 
readout was performed each time before and after the irradiation by pushing the 
MANUAL READ button on the CSDS. As mentioned in Chapter 2.5.4, MOSFET reading 
drifts slightly after the exposure. So, a consistent delay of 30 seconds was taken each time 




Figure 15. Clinical Semiconductor Dosimetry System developed by the Centre for Medical Radiation 
Physics (CMRP). A MOSkin detector is connected via a cable. 
 
3.4 Thermoluminescent dosimeters 
For calibration, eight TLD-100 chips (3.2 mm x 3.2 mm x 0.9 mm) (Harshaw-
Bicron, Solon, OH, USA) were placed within a calibration tray which arranges the TLDs 
in a circle equidistant from central axis of the radiation beam. Calibration was performed 
using a 6 MeV electron beam with the standards at the depth of maximum dose, dmax of 
1.3 cm in a Solid Water phantom using a 10 cm x 10 cm applicator. The expected accuracy 
estimated from the calibration data was within ± 1.9 %. For TSET measurements, pairs 
of different but same sized TLD-100 chips (with known dose sensitivity) were packed by 
using small paper snips, a thin plastic foil and sticky tape as shown in Figure 16. TLDs 
must be handled with care because scratches or contamination of the surface of the 
material could reduce the emission of the light from the material. (4) TLD annealing and 
dose reading procedures were performed according to the Prince of Wales Hospital 
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Radiation Oncology Medical Physics departmental protocols. These protocols date back 
to work done by Amies et al. (70). A RadPro oven (RadPro international GmbH, 
Wermelskirchen, Germany) was used for pre-read (100 °C for fifteen minutes) and post-
read (400 °C for an hour) annealing process and the Harshaw-Bicron 5500 Automatic 




Figure 16. TLD packaging for in vivo dosimetry (reproduced from (4)) 
 
3.5 Radiochromic film 
 Gafchromic EBT3 films (Ashland Specialty Ingredients, Wayne, NJ, USA) with 
dimensions 5 cm x 5 cm were prepared. For calibration purpose, 8 pieces of film were 
irradiated at dmax of 1.3 cm using 6 MeV electron beam under conditions of 100 cm SSD, 
10 x 10 cm2 field size to different doses of 0, 20, 60, 100, 140, 180, 220, and 260 cGy.  
For total skin electron therapy (TSET) skin dose measurements, thin plastic foil (cling 
wrap) was used to cover the EBT3 films to protect the film surface when attaching onto 
the cylindrical phantom. The Epson 10000XL Photo flatbed colour scanner (Epson 
America Inc., Long Beach, CA, USA) was used for pre- and post-irradiation scans. For 
scanning, the plastic foil was removed from the film and surface marks left on the film 
surface was negligible. A warm-up procedure was carried out and the scanner’s flatbed 
surface was cleaned before scanning films. Every film was scanned with the same 
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orientation to minimise polarisation effect. Calibration and the dose readings were 
performed by using in-house software developed by Dean Inwood, a Radiation Oncology 
Medical Physicist at the Prince of Wales Hospital. 
 
Figure 17. Gafchromic EBT3 film calibration curve 
 
Figure 17 shows the calibration curves for red, green, and blue channels. Each 
curve is fitted with a third order polynomial and shows the fit of the regression line. It 
appears that the red channel has a higher response than other channels up to 260 cGy. 
Therefore, due to the higher sensitivity and greater degrees of the calibration curve, the 
dose was read from the red channel. 
 
3.6 Calibration, dose linearity and lifetime of MOSkin detector 
Measurements of calibration, dose linearity, percentage depth dose and angular 
response of the MOSkin for 6 MeV electron beam were performed with a 10 cm x 10 cm 
y = 263.48x3 + 429.03x2 + 564.94x + 0.9611
R² = 1
y = 327.67x3 + 464.51x2 + 1043x + 3.0387
R² = 1




















electron applicator. A MOSkin was calibrated at the central axis of the 6 MeV electron 
beam at the depth of 1.3 cm (dmax) in 30 cm x 30 cm Solid Water, 10 cm backscatter, 100 
cm source to surface distance (SSD), and 10 x 10 cm2 field size. The linearity of the 
detector was tested within the dose range of 2 to 8 Gy with an increment of 2 Gy and 
reproducibility was determined from the average standard deviation of three repeated 
measurements at each dose level. The MOSkin was irradiated with the face-up orientation 
(as appeared on Figure 14(c)). 
 
Figure 18. Setup for MOSkin calibration and dose response at depth of 1.3 cm 
 
A new, non-used, MOSkin detector was used to verify changes in sensitivity as a 
function of accumulated dose throughout its lifetime. For this measurement, the doses of 
200 cGy were constantly delivered per beam until the gate threshold voltage of the 
MOSkin detector reached the maximum and become unable to provide a dose reading. 
33 
 
Changes in the gate threshold voltage of the MOSkin detector were recorded for each 
beam and the sensitivity of the detector was calculated for the accumulated dose. 
 
3.7 Percentage depth dose measurement 
 Percentage depth dose (PDD) curves of the 6 MeV electron beam were obtained 
with both a MOSkin detector and a PTW Roos parallel plate chamber (PTW-
Freiburg GmbH, Freiburg, Germany). The Roos electron chamber is regarded as a 
reference class electron chamber and is recommended for precise dosimetry of high 
energy electron beams (68, 71). It has the inherent build-up of 1.3 mm and the effective 
point of measurement is at 1.12 mm depth from the surface (71). The depth ionisation 
distribution measured with Roos chamber were converted to depth dose distribution by 
multiplying the charge at each depth by the stopping power ratio (sw,air) of the same depth 
in accordance with the IAEA TRS-398 for the electron beam energy (50). The MOSkin 
detector was embedded onto the slit of this phantom in a face-up orientation and 
connected to the electrometer via a cable. The readout was performed each time before 
and 30 seconds after the irradiation to stabilise the gate voltage reading. Percentage depth 
dose measurements were performed under the conditions of 10 x 10 cm2 field size, and 
10 cm backscatter. Note that the PDD measured for testing the MOSkin was not 
performed at the TSET conditions but instead at 100 cm SSD for convenience. For PDD, 
doses were delivered 50 MU per beam for the range of depth from the surface to 25 mm 




3.8 Angular response 
 Measurements were performed for the response of the MOSkin and Gafchromic 
EBT3 film with respect to incident beam angle on the surface and at 1 mm depth of 30 
cm x 30 cm sized Solid Water phantom for 6 MeV electron beam. The dose was delivered 
at gantry angles of 0, 15, 30, 45 and 60 degrees under the conditions of 100 MU per beam, 
10 cm x 10 cm field, SSD 100 cm. The same MOSkin used for PDD measurement was 
used for this measurement. For film dosimetry, mean optical density was calculated from 
the centre of each film and the region of interest was 2 x 2 cm in size. The dose response 
curves were produced 24 hours after the irradiation and fitted with a third order 
polynomial. 
 




3.9 Dose rate dependence 
 According to Di Martino, F., et al., a parallel-plate ionisation chamber is 
recommended for measuring accurate absorbed dose in pulsed high energy electron 
beams (72). Electron beams that are used in radiotherapy are pulsed beams and typically 
have less than 0.1 cGy of dose per pulse (72). Within this range, it is recommended that 
a correction factor ks  be evaluated by using the two-voltage method to correct the 
incomplete charge collection response of an ionisation chamber caused by the ion 
recombination (10, 50, 73). The incomplete charge collection in an ionisation chamber 
depends on the dose rate (10, 50). The ion recombination factor ks can be found from the 
equation below. 
ks = a0 + a1 (
M1
M2





          (9) 
Where ax  are coefficients for the calculation of ks  by the two-voltage method as a 
function of the voltage ratio V1/V2 (10, 50, 74). The polarising voltage V1 is the voltage 
normally used for operating the ionisation chamber and V2 is the voltage lower than V1. 
M1 and M2 are charges collected at V1 and V2 respectively. In this experiment, the Roos 
chamber was used and charges were collected at 300 V (V1) and 100 V (V2). So, for the 
voltage ratio (V1/V2) of 3, coefficients used for ks calculation were a0 = 1.198, a1 = -0.875, 
and a2 = 0.677 (10, 50). 
Both the Roos chamber and MOSkin were measured for the 6 MeV electron beam 
at dmax of 1.3 cm at the different source to surface distances (SSD) from 100 cm to 146 
cm with 10 cm increments. Measurements were repeated twice at each SSD point and 




3.10 Total skin electron therapy (TSET) measurement 
 All three different types of detectors (Gafchromic EBT3 film, TLD, and MOSkin) 
were calibrated for 6 MeV electron beam under the conditions of 1.3 cm depth (dmax) in 
30 cm x 30 cm solid water, 5 cm backscatter, 100 cm SSD, and 10 x 10 cm2 field size and 
sensitivities were calculated before the TSET measurement. For TSET measurement, an 
18 cm diameter cylindrical phantom and a rotating platform were used and detectors were 
placed on the surface of the cylindrical phantom; TLDs placed 3 cm above and MOSkin 
detectors placed 3 cm below from the centre of Gafchromic EBT3 films, as shown on 
figure 20, for a direct comparison of measured dose. These detectors were then covered 
by a 1 mm of the tissue equivalent plastic sheet for build-up to measure the skin dose at 
the prescription depth of 1 mm (21). 
 
Figure 20. Three different types of dosimeters used for TSET measurement. TLD packet (top), 3 pieces of 
Gafchromic EBT3 films (middle), 3 MOSkin detectors (bottom) 
 
Measurements were performed using a 6 MeV high dose rate electron (HDRE) 
beam under the clinical treatment conditions of 350 cm SAD (source to rotation axis 
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distance), 1mm build-up layer (prescription depth), 40 x 40 cm2 field size. The eight static 
dual-field technique was chosen for the experimental measurements, instead of the 
rotational technique because, just like the MOSFET, the MOSkin needed a cable for 
external gate voltage supply to keep stable detector sensitivity. The nominal patient 
diameter is approximately 30 cm and therefore the measurements were taken at the SSD 
(source to surface distance) of 335 cm. TSET dose was delivered in two fields using 
gantry angle of 252° (superior field) and 288° (inferior field) and measurements were 
taken at different heights; 20 cm, 55 cm, 90 cm, 130 cm, 170 cm from the rotating 
platform. A modified Stanford irradiation technique (8 static dual fields) was used and 
the TSET dose was delivered in 8 directions per field (anterior, posterior, right lateral, 
left lateral, right anterior oblique, left anterior oblique, right posterior oblique and left 
posterior oblique as appeared on Figure 9 in Chapter 2). 
 
Figure 21. Geometrical setup of dual field (superior and inferior) technique.
 
Currently, at Prince of Wales Hospital, the linac is calibrated under TSET 
treatment conditions of 335 SSD, 350 SAD, 1 mm prescription depth, 40 x 40 cm2 field, 
866 monitor units (MU) per field and 310 MU/min dose rate to provide average surface 
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dose of 222.8 cGy across a total combined beam junction of superior and inferior beams 
using a rotational technique. A 6 mm Perspex spoiler is placed at the same distance as 
used clinically and aligned perpendicularly to the beam to lower the effective beam 
energy and increase the surface dose.  
For these experiments, the prescribed skin dose at 1 mm depth was chosen to be 
200 cGy. The PDD curve of 6 MeV HDR electron beam under TSET treatment conditions 
of a rotating patient with a 6 mm spoiler is shown in figure 22.  This graph is used for 
calculating required MU for each treatment fraction at Prince of Wales Hospital if the 
depth of prescription was not at the surface. The R50 (the depth where the absorbed dose 
falls to 50% of the maximum dose) estimated from this data is approximately 12.3 mm 
and the mean surface energy calculated by using the equation (2) is approximately 2.9 
MeV. 
 
















In the case of these experiments, the dose was prescribed to 1 mm depth. So, for 
prescription dose of 200 cGy at the prescription depth of 1mm 
 Percentage depth dose (PDD) = 100 % 
 Prescribed surface dose = 200 / 1.00 
       = 200 cGy 
And the required monitor unit for TSET is calculated by 
Required MU  =  
Calibrated MU per field ×Prescribed surface dose
Calibration dose
           (10) 
=  
866 MU × 200 cGy
222.8 cGy
 
= 777.4 MU per field 
This 777.4 MU would normally be prescribed as a rotational delivery where the patient 
would undergo 7 complete rotations during each 777.4 MU exposure. An assumption was 
made that the 777.4 MU exposure would give the same approximate dose to the phantom 
if the MU were equally divided across the eight fields.  That is, 97.2 MU per patient 
orientation (see figure 9 in chapter 2).  This assumption can be made since the significance 
of the results is the comparison of the dose measured by the MOSFETs compared to the 




4. RESULTS AND DISCUSSIONS 
4.1 Calibration, dose linearity and lifetime of MOSkin detector 
The MOSkin detector was calibrated and the average sensitivity was calculated as 
2.392 ± 0.027 mV/cGy for this study. MOSkin dose response was observed to be 
effectively linear (R2 = 0.9986) over 3 Gy of total dose. 
 
Figure 23. Dose linearity of the MOSkin detector 
 
The maximum difference from the linear curve was found to be 8.1 % at the dose 
of 5 cGy. It is noticeable that the difference in gate threshold voltage response decreases 
with the cumulative dose. Studies have found that, in x-ray photon beams, the sensitivity 
of the MOSFET detector decreases by 0.09 mV/cGy for every 10 Gy of accumulated dose 
(6, 75). The dose response of the MOSkin detector is effectively linear until the gate 
























Figure 24. MOSkin detector response throughout its lifetime 
 
Measurements were taken throughout the lifetime of the MOSkin detector with 6 
MeV electron beams. In general, similar to its behaviour in photon beams, the sensitivity 
of the MOSkin detector decreases as a function of the accumulated dose. According to 
Jong et al., the sensitivity of the MOSkin decreases with accumulated dose by 
approximately 0.4 % for every 100 cGy for 6 MV photon beam (6). 
The changes in sensitivity are effectively linear between the accumulated doses 
of 1000 cGy and 7800 cGy. The gate threshold voltage reading at the accumulated dose 
of 1000 cGy was 11.657 V and at the accumulated dose of 7800 cGy was 25.853 V. 
Initially, the calculated sensitivity was 2.445 mV/cGy at the accumulated dose of 200 
cGy and 1.91 mV/cGy at the accumulated dose of 7800 cGy. This indicates that the 
sensitivity of the MOSkin detector decreases by 6 x 10-3 mV/cGy (approximately 0.3 % 
changes) for every 100 cGy. The mean sensitivity was 2.142 mV/cGy. The maximum 
gate threshold voltage of the MOSkin detector was recorded 26.974 V. Changes in 































sensitivity are effectively linear and the changes in percentage are very low. So, the 
MOSkin detector can provide acceptable dose readings until the gate threshold voltage 
reading reaches approximately 26 V. With this data, the MOSkin sensitivity at each 
measurement will be known from the accumulated dose. However, recalibration of the 
MOSkin detector must be carried out regularly to be able to obtain accurate dose readings. 
 
4.2 Percentage depth dose measurement 
 The response of the MOSkin was similar to the Roos chamber within the build-up 
region and at dmax although 1.7 % of difference was measured at 1mm depth. In the dose 
fall-off region, the estimated R50 measured with MOSkin is 25.29 ± 0.14 mm while 24.80 
± 0.014 mm with the Roos chamber which is approximately 0.49 ± 0.15 mm difference 
in depth. So, the MOSkin tends to overestimate the R50 when compared to the Roos 
chamber. The uncertainties of both detector types were estimated based on the average 
standard deviation of three repeated measurements at each depth. The Range of error in 
the R50 were estimated by interpolating the larger and smaller errors in each point 
measurements along the PDD curves of both detectors, so that the depths where these 




Figure 25. Percentage depth dose data of 6 MeV electron beam measured with MOSkin and Roos 
chamber 
 
The MOSkin is a MOSFET based detector and its sensitive volume is made of 
silicon. Therefore, it exhibits little energy dependence. According to the ESTAR stopping 
power and range tables for electrons provided by the National Institute of Standards and 
Technology, USA (NIST), the total stopping power for a 6 MeV electron for Silicon is 
1.813 MeV cm2/g whereas 2.010 MeV cm2/g for water, 1.995 MeV cm2/g for soft tissue, 
1.982 MeV cm2/g for skin and 1.937 MeV cm2/g for Perspex (77). So, it tends to under 
respond for higher energies at shallow depths and over respond for lower energy at deeper 
depths when compared to ionisation chamber (78, 79). With the R50 measured from the 
PDD data, the mean surface energy could be calculated by using the equation (2) as 


























4.3 Angular response 
 
Figure 26. Angular response of MOSkin detector and Gafchromic EBT3 film 
 
Figure 26 shows the angular response of MOSkin and Gafchromic EBT3 film that 
have been normalised to the incident angle of 0 degree. The uncertainties of both detector 
types were estimated based on the average standard deviation of two repeated 
measurements at each angle. In general, it appears that the dose measured with both 
dosimeters increases gradually as the incident beam angle increases. This is because the 
charged particle equilibrium (CPE) region moves towards the phantom surface as the 
beam angle increases (6). The CPE exists where the number of charged particles entering 
is equal to the leaving and the dose is equal to the collisional kerma (4). A fraction of 
incident electrons undergo radiative energy loss including Bremsstrahlung production 
within the phantom and thus the deposited dose is equal to the collisional kerma but 
smaller than kerma (4). Doses were measured higher with EBT3 film than the MOSkin 









































layer as water equivalent depth (WED) of the MOSkin detector is approximately 0.07 mm 
while WED of EBT3 film is approximately 125 µm (42). According to Suchowerska et 
al., radiochromic film is nearly angular independent (80) and, as shown above, the 
MOSkin detector behaves very similarly to the Gafchromic EBT3 film. Experimental 
random errors might be present when handling and/or taking measurements with 
Gafchromic EBT3 film as differences appeared at 1 mm depth at the gantry angle of 30 
degrees (5.9 % difference) and on the surface at 60 degrees (4.7 % difference). The 
expected accuracy estimated from the calibration data was within ± 0.8 %. 
 
4.4 Dose rate dependence 
The graph below illustrates the dose responses of Roos chamber and MOSkin 
detector at different SSD. 
 


































Data for the Roos chamber were corrected for ion recombination and all measured 
doses were normalised to the meter reading at 100 cm SSD. As the graph illustrates, the 
Roos chamber and MOSkin show similar response with less than 1% difference over 100 
cm to 140 cm SSD. This result indicates that MOSkin is almost dose rate independent 
over 100 cm to 140 cm SSD for 6 MeV pulsed electron beam. The maximum percentage 
difference of 1.5 % was found at SSD of 146 cm. 
 
4.5 TSET measurement 
Before the TSET measurements, three MOSkin detectors were calibrated and 
calculated sensitivities of MOSkin #1, 2 and 3 were 2.417 ± 0.014 mV/cGy, 2.4 ± 0.025 
mV/cGy, and 2.458 ± 0.038 mV/cGy respectively. 
 
































The graph above shows the measured doses with MOSkin, TLDs, and Gafchromic 
EBT3 films at different heights above the rotating platform under clinical TSET condition. 
In general, all three detector types showed a very similar trend of dose readings over every 
measurement points. Except for the dose readings with ‘MOSkin #3’ at 87 cm and 127 
cm, all MOSkin dose readings are within the ranges of the other two dosimeters at all 
measured points. So, this proves that the MOSkin provides stable skin dose readings for 
TSET dosimetry that compared acceptably with the TLD and Gafchromic EBT3 film. 
The combined field is determined by two overlapping beams, one of which may have 
additional scatter from the floor or the base of the Perspex screen and the rotating platform. 
This might be the reason for the higher dose readings at 20 cm and 55 cm. The measured 
doses at 90 cm indicates the junction of superior and inferior treatment fields while the 
doses at 55 cm and 130 cm indicate the central axis of each treatment field. The maximum 
percentage difference calculated between TLD readings and the average MOSkin 
readings were 8.2% at 52 cm and 4.5 % at 87 cm. TSET measurement was performed 
once only and the uncertainties of TLD and film readings were estimated based on the 
average standard deviation of two TL crystals and three films at each measurement point. 
Random errors might be present within the dose readings particularly at 20 cm and 55 cm. 
The possible source of errors might be present when preparing TLD patches and wrapping 
films individually. Marks presented on the film surfaces after removing thin plastic foils 
for dose analysis might also affect the dose readings. 
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5. CONCLUSIONS AND FUTURE DEVELOPMENTS 
Characteristics of the MOSkin detector for a 6 MeV electron beam showed that it 
behaves very similar to the other types of dosimeters that are commonly used in vivo 
dosimetry. The MOSkin detector showed an effectively linear dose response. Although 
the sensitivity of the MOSkin detector decreases as a function of the accumulated dose, 
the trend was still very similar to its behaviour in photon beams. The changes in 
sensitivity are effectively linear between the accumulated doses of 1000 cGy and 7800 
cGy and proved that it provides acceptable dose readings until the gate threshold voltage 
reading reaches approximately 26 V. The PDD data showed that the MOSkin responses 
similarly to the Roos chamber within the build-up region and at dmax for a 6 MeV electron 
beam. It also behaved similarly to Gafchromic EBT3 film when surface doses were 
measured at different incident beam angles. The MOSkin detector is almost dose rate 
independent over 140 cm SSD for 6 MeV pulsed electron beam although the maximum 
percentage difference of 1.5 % was found at SSD of 146 cm. For TSET dosimetry, it 
provided stable skin dose readings that compared acceptably with the TLD and EBT3 
film results. Therefore, the MOSkin detector is an effective skin dosimeter for TSET 
dosimetry and it could be an alternative for in vivo skin dosimetry during electron beam 
therapy. 
For future developments of a MOSkin detector system for in vivo TSET 
measurements, the application of a wireless system for MOSkins could be a huge 
advantage in a clinical environment, particularly as the skin doses need to be measured 
from 30 different spots on patient’s body. For keeping high and stable detector sensitivity, 
the MOSkin needs to be operated in active mode (with the external gate voltage supply) 
and a cable needs to be connected while operating. So, an external gate voltage supplying 
electrometer that is mobile and can be kept within the treatment room is necessary to be 
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used in a clinical environment. CMRP developed a wireless electrometer system for the 
MOSkin detector, called OneTouch MOSkinTM appeared on figure 29. It is mobile (battery 
operated), small, and light. So, by placing it on the top of the treatment frame or on the 
rotating platform, the TSET could be performed by using either rotational or static 
irradiation techniques while operating the MOSkin detectors in active mode. A new 
design that can operate multiple MOSkin detectors (up to 30) to be operated 
simultaneously is needed as the current model allows only up to 6 MOSkin detectors. 
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